Navigation Links
Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
Date:11/4/2008

SAN DIEGO, Nov. 4 /PRNewswire/ -- Accumetrics, Inc. announces the appointment of William H. Dippel to the position of Executive Vice President of Operations and R&D. Mr. Dippel will oversee the Operations, Research and Product Development departments at Accumetrics.

"We are excited to have Bill join our team," said Timothy Still, President and Chief Executive Officer of Accumetrics. "Bill's 33 years of operations and R&D experience in the healthcare industry will be a tremendous asset to Accumetrics."

Prior to joining Accumetrics, Mr. Dippel was Vice President of Operations at Barrx Medical, Inc. Before joining Barrx, Mr. Dippel was Executive Vice President of HemoSense, Inc., responsible for R&D, Manufacturing, Engineering, Materials, and Facilities Management. He provided strong leadership introducing lean manufacturing resulting in improvements in gross margin, and later played a key role during the acquisition of HemoSense by Inverness Medical Innovations.

Prior to that position, Mr. Dippel was Vice President of Operations for Micro Therapeutics -- eV3. Earlier in his career, Mr. Dippel was with Conceptus, Inc. as Vice President of R&D and Operations, and PercuSurge (now a division of Medtronic, Inc.) as Vice President of Operations and held senior positions with Boehringer Mannheim GmbH (now Roche Diagnostics), Ciba Corning Diagnostic Corporation and Spectrum Technology, Inc.

Mr. Dippel holds a B.S. in Mechanical Engineering from the California State Polytechnic University, Pomona, California.

About Accumetrics

Accumetrics is committed to advancing medical understanding of the platelet function and enhancing the quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow(R) System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

Contact:

Jules Abraham

Lippert/Heilshorn & Associates

212-838-3777

jabraham@lhai.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Novo Nordisk Appoints New Leader of North American Business
3. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
4. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
5. Resonant Medical Appoints New Vice President of Global Sales
6. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
7. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
8. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
9. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
10. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
11. Adlyfe Appoints Roxanne Duan as Vice President of Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... ... speaker, trainer and author Ray Clarke poses a question as a challenge for ... In his book, "Being in the Being" (published by Partridge Singapore), Clarke explores ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... Colorado spine ... as one of 334 spine surgeons to know in 2016 . The list ... the field of spine surgery. , Dr. Corenman understands the importance of clinical ...
(Date:2/11/2016)... Rock, AR (PRWEB) , ... February 11, 2016 , ... ... in their community by announcing a new fundraiser in support of a local boy ... also hopes the campaign will bring awareness to, and rally support for, all local ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... the American Academy of Dermatology Annual Meeting at the Walter E. Washington Convention ... raise awareness for both the condition of hyperhidrosis (excessive sweating) and its treatment ...
(Date:2/11/2016)... ... February 11, 2016 , ... The book, “Computers Should Just Work!”, provides ... to ask your IT consultant before signing a contract and how to spot an ... “With companies relying heavily on e-mail and technology, it’s more important than ever to ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... The primary goal of this research is ... the usage of liquid biopsy. Key information the survey ... Timeframe of liquid biopsy adoption amidst future users - ... type - Sample inflow to conduct liquid biopsy tests ... and so on. - Correlation analysis of sample type ...
(Date:2/11/2016)... Feb. 11, 2016 Laboratory glassware ... in laboratories. These may range from microscope slides to ... is made from borosilicate glass because of its low ... the other hand, started gaining popularity over the past ... to replace glass with plastic in several applications due ...
(Date:2/11/2016)... -- Governor Andrew M. Cuomo today announced a major expansion ... Western New York . This announcement, made ... includes a major expansion of Athenex,s North American headquarters ... , as well as the creation of a state-of-the-art, ... . The combined projects are expected to yield ...
Breaking Medicine Technology: